FIVE PRIME THERAPEUTICS INC — Form D

FIVE PRIME THERAPEUTICS INC of SOUTH SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2012-04-20. The offering totals $10.0M, of which $10.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (34)

Showing 25 of 34 people.

NameRoleLocation
Brian K AtwoodDirectorMenlo Park, CA
Franklin T BergerDirectorSouth San Francisco, CA
Brook K ByersDirectorMenlo Park, CA
Fred K CohenDirectorSan Francisco, CA
Robert Lee DouglasDirectorThe Woodlands, TX
Peder K JensenDirectorSouth San Francisco, CA
Mark T McDadeDirectorSouth San Francisco, CA
Lewis T WilliamsDirectorSouth San Francisco, CA
Marc Michael BelskyExecutive OfficerSouth San Francisco, CA
Lauretta Michael CesarioExecutive OfficerSouth San Francisco, CA
W. Michael KavanaughExecutive OfficerSouth San Francisco, CA
Aron Michael KnickerbockerExecutive OfficerSouth San Francisco, CA
Francis K SarenaExecutive OfficerSouth San Francisco, CA
Lewis T WilliamsExecutive OfficerSouth San Francisco, CA
Julia P GregoryDirectorDartmouth, A5
Julia P GregoryExecutive OfficerDartmouth, A5
Mark D McDadeDirectorMenlo Park, CA
Brian G AtwoodDirectorGaithersburg, MD
W. Michael Kavanaugh, M.D.Executive OfficerSouth San Francisco, CA
R. Lee DouglasDirectorSouth San Francisco, CA
Fred E Cohen, M.D., D.Phil.DirectorSouth San Francisco, CA
Franklin M Berger, CFADirectorSouth San Francisco, CA
Julie L Hambleton, M.D.Executive OfficerSouth San Francisco, CA
Francis W SarenaExecutive OfficerSouth San Francisco, CA
Peder K Jensen, M.D.DirectorSouth San Francisco, CA

Other filings by this issuer (2)

FiledFormOfferingSold
2014-03-26D$21.0M$21.0M
2010-09-16D$7.5M$7.5M

More